PepGen Inc. financial data

Symbol
PEPG on Nasdaq
Industry
Pharmaceutical Preparations
Location
1 Marina Park Drive, Suite 900, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 882 % +3.38%
Debt-to-equity 23.1 % -3.15%
Return On Equity -60.2 % -25.4%
Return On Assets -48.9 % -26.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.6M shares +36.9%
Common Stock, Shares, Outstanding 23.8M shares +0.46%
Entity Public Float 97.7M USD
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 32.6M shares +37%
Weighted Average Number of Shares Outstanding, Diluted 32.6M shares +37%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 73.8M USD +13.6%
General and Administrative Expense 20.4M USD +26%
Operating Income (Loss) -94.2M USD -16.1%
Nonoperating Income (Expense) 7.04M USD +10.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -87.2M USD -16.6%
Net Income (Loss) Attributable to Parent -87.2M USD -17.8%
Earnings Per Share, Basic -2.97 USD/shares -121%
Earnings Per Share, Diluted -2.97 USD/shares -121%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 42.3M USD -67.4%
Marketable Securities, Current 96.6M USD
Cash, Cash Equivalents, and Short-term Investments 139M USD
Assets, Current 142M USD +6.97%
Property, Plant and Equipment, Net 3.9M USD -22.6%
Operating Lease, Right-of-Use Asset 22M USD -8.94%
Other Assets, Noncurrent 426K USD -78.6%
Assets 170M USD +3.63%
Accounts Payable, Current 5.93M USD +48.7%
Employee-related Liabilities, Current 3.14M USD +62.5%
Accrued Liabilities, Current 7.81M USD -44.2%
Liabilities, Current 16.8M USD -19.8%
Operating Lease, Liability, Noncurrent 16M USD -8.49%
Liabilities 32.8M USD -14.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 91K USD
Retained Earnings (Accumulated Deficit) -249M USD -53.9%
Stockholders' Equity Attributable to Parent 137M USD +9.21%
Liabilities and Equity 170M USD +3.63%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -22.5M USD -46.1%
Net Cash Provided by (Used in) Financing Activities 87M USD +66798%
Net Cash Provided by (Used in) Investing Activities -11.3M USD -856%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 23.8M shares +0.46%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 53.1M USD
Deferred Tax Assets, Valuation Allowance 50.2M USD +133%
Deferred Tax Assets, Gross 58.1M USD +109%
Operating Lease, Liability 20.1M USD -17.9%
Depreciation 376K USD +151%
Payments to Acquire Property, Plant, and Equipment 53K USD -95.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -87.1M USD -17.7%
Lessee, Operating Lease, Liability, to be Paid 28M USD -17.3%
Property, Plant and Equipment, Gross 6.59M USD +5.25%
Operating Lease, Liability, Current 3.07M USD +2.99%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.09M USD +2.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 3M USD -52.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.92M USD -15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.19M USD +2.02%
Deferred Tax Assets, Operating Loss Carryforwards 8.04M USD +1596%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 700K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.28M USD +1.99%
Depreciation, Depletion and Amortization 1.6M USD +60%
Deferred Tax Assets, Net of Valuation Allowance 50.2M USD +133%
Share-based Payment Arrangement, Expense 10M USD +54.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%